Abstract
Nine long-term canine radiation chimeras and their canine histocompatibility locus (DL-A) compatible, mixed leukocyte culture negative littermate marrow donors were studied between 545 and 1282 days after 1,200 R total body irradiation and marrow grafting. Before the time of testing, marrow donors were immunized against their chimeras by repeated skin grafts which they rejected. Skin fibroblasts from chimeras and their donors were tested for cell inhibition (CI) in the microcytotoxicity assay by exposure to lymphocytes from chimeras, donors and normal dogs and the effects of various sera on CI were evaluated. Lymphocytes from sensitized marrow donors consistently inhibited fibroblasts from the chimeras (eight of nine dogs); CI was abrogated by chimeric serum in only three of eight cases. Only two chimeras showed consistent CI of their “own” fibroblasts; CI was blocked by chimeric serum in one of the two. The remaining seven chimeras did not show consistent CI.
Sequential studies in 16 additional recipients of DL-A compatible littermate marrow were carried out from 45 to 439 days after marrow grafting. Seven of the 16 did not show CI of chimeric fibroblasts by chimeric lymphocytes at any time. Nine showed CI on one or several occasions. Serum blocking factors were seen on one occasion in each of two chimeras.
In conclusion, the CI assay is able to detect immunity against “minor” histocompatibility systems in dogs. Both long- and short-term chimeras occasionally demonstrated CI of chimeric fibroblasts but serum blocking factors did not appear to be necessary for maintaining stable grafthost “tolerance.”.
Footnotes
-
↵2 Dr. Weiden is a fellow of the American Cancer Society.
-
↵3 Dr. Schroeder is a recipient of a Centennial Fellowship from the Canadian Medical Research Council.
-
↵4 Dr. Thomas is the recipient of Research Career Award AI 02425 from the National Institute of Allergy and Infectious Diseases.
-
↵1 This investigation was supported by Public Health Service Grants AI 09419 from the Institute of Allergy and Infectious Diseases and CA 05231 from the National Institutes of Health, and Contract CP-3-3236 within The Virus Cancer Program of the National Cancer Institute.
- Received September 27, 1974.
- Copyright © 1975 by The American Association of Immunologists, Inc.
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.50
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.